4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001179110-15-008414
CIK 0001600132operating
Filed
May 21, 8:00 PM ET
Accepted
May 22, 7:32 AM ET
Size
4.5 KB
Accession
0001179110-15-008414
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2015-05-20$8.40/sh+712$5,981→ 19,098 total
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 7:32 AM ET
- Size
- 4.5 KB